Dr. Neal-Perry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UNC Fertility
7920 ACC BLVD Unit 300
Raleigh, NC 27617Phone+1 919-908-0000Fax+1 919-966-6049
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Reproductive Endocrinology and Infertility, 2002 - 2005
- Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Obstetrics and Gynecology, 1998 - 2002
- Rutgers Robert Wood Johnson Medical SchoolClass of 1998
Certifications & Licensure
- WA State Medical License 2014 - 2026
- NC State Medical License 2020 - 2025
- NY State Medical License 2002 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Publications & Presentations
PubMed
- Substance use and menopausal symptoms among people with and without HIV in the US, 2008-2020.Andrea K Knittel, Brooke W Bullington, Andrew Edmonds, Lisa Rahangdale, Genevieve Neal-Perry
Menopause. 2024-10-01 - 2 citationsDisparities in menopausal care in the United States: A systematic review.Katelin Zahn, Allison Pittman, Jamie Conklin, Andrea Knittel, Genevieve Neal-Perry
Maturitas. 2024-08-01 - 2 citationsEx ovo omnia-why don't we know more about egg quality via imaging?Caitlin F Boylan, Keshia M Sambo, Genevieve Neal-Perry, Lynae M Brayboy
Biology of Reproduction. 2024-06-12
Authored Content
- Religiosity and Faith in Relation to Time to Metabolic Syndrome for Hispanic Women in a Multiethnic Cohort of Women—Findings from the Study of Women’s Health Across the Nation (SWAN)March 2018
- Religiosity and Faith in Relation to Time to Metabolic Syndrome for Hispanic Women in a Multiethnic Cohort of Women—Findings from the Study of Women’s Health Across the Nation (SWAN)March 2018
Press Mentions
- Veozah (Fezolinetant) Is a New Type of Drug for Menopausal Hot FlashesMay 17th, 2023
- Results from Astellas' Pivotal Phase 3 SKYLIGHT 1™ Study of Fezolinetant for Vasomotor Symptoms Due to Menopause Published in the LancetMarch 13th, 2023
- Nonhormonal Drug Fezolinetant Found Safe for Hot Flashes in Yearlong StudyOctober 19th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: